(PRNewsChannel) / December 23, 2009 / Orlando, Fla. / Dr. Stephanie Haridopolos says the average person will not see any problems following the latest H1N1 vaccination recall. AstraZeneca recalled 4.7 million doses of the nasal vaccine after routine tests showed a decline in potency.
“Basically, the unused vaccines became weaker over time,” says the Orlando family practitioner. “The drug maker recalled the product because it wants to ensure everyone gets a proper dose. People who were already given the nasal vaccine have nothing to worry about.”
This is the second H1N1 vaccine recall this month. A week ago, Sanofi-Aventis recalled 800,000 doses of its children vaccine because it had also lost some potency.
“It is uncommon to have two vaccine recalls in a single flu season,” said Dr. Haridopolos. “But you have to keep in mind that the vaccines are made from live organisms, so it can decrease in potency over time.”
Dr. Haridopolos is represented by The Publicity Agency, which has offices in Tampa, Los Angeles and Chicago.
For more information, please visit www.thepublicityagency.com.
Media Contacts:
Kimberly Polacek
PR Firm: The Publicity Agency
Email: kpolacek@seligmultimedia.com
Phone: (813) 708-1220 x 7780 or (813) 504-9706
Web site: www.thepublicityagency.com
Justin Herndon
PR Firm: The Publicity Agency
Email: justin@thepublicityagency.com
Phone: (813) 708-1220 x 7778 or (813) 528-6815
Web site: www.thepublicityagency.com
RSS Feed
